Optima Medical Innovations Corp.
TOKIF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $4,614 | $5,495 | $695 | $1 |
| % Growth | -16% | 690.8% | 97,772% | – |
| Cost of Goods Sold | $3,233 | $9,679 | $6,563 | $0 |
| Gross Profit | $1,381 | -$4,184 | -$5,868 | $0 |
| % Margin | 29.9% | -76.1% | -844.5% | 63.9% |
| R&D Expenses | $98 | $34 | $64 | $0 |
| G&A Expenses | $2,880 | $7,293 | $7,520 | $106 |
| SG&A Expenses | $2,880 | $2,881 | $1,465 | $106 |
| Sales & Mktg Exp. | $0 | -$4,412 | -$6,056 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,977 | $2,915 | $1,528 | $106 |
| Operating Income | -$1,597 | -$7,099 | -$7,396 | -$6 |
| % Margin | -34.6% | -129.2% | -1,064.4% | -790.9% |
| Other Income/Exp. Net | -$2,364 | -$10,474 | -$6,569 | -$32 |
| Pre-Tax Income | -$3,961 | -$18,042 | -$13,966 | -$138 |
| Tax Expense | $0 | $0 | $0 | -$27 |
| Net Income | -$3,961 | -$18,042 | -$14,903 | -$138 |
| % Margin | -85.9% | -328.3% | -2,144.6% | -19,377.7% |
| EPS | -0.016 | -0.42 | -1.04 | -0.001 |
| % Growth | 96.2% | 59.6% | -86,566.7% | – |
| EPS Diluted | -0.016 | -0.42 | -1.04 | -0.001 |
| Weighted Avg Shares Out | 243,250 | 43,006 | 14,272 | 117,316 |
| Weighted Avg Shares Out Dil | 243,250 | 43,006 | 14,272 | 117,316 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $21 | $0 | $0 |
| Interest Expense | $521 | $220 | $6 | $3 |
| Depreciation & Amortization | $728 | $1,354 | $170 | $0 |
| EBITDA | -$2,894 | -$16,463 | -$13,790 | -$135 |
| % Margin | -62.7% | -299.6% | -1,984.5% | -18,984.6% |